Payment overview · 2025
General Payments
$17.40
1 reported records · 1 companies
Healthcare provider profile · identity verified
William Ward, MD
Allopathic & Osteopathic Physicians|Family Medicine · WOODLAWN, VA · NPI 1740252998
Verified facts
What the public records show
CMS Open Payments records show William Ward, MD received $17.40 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 488 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.40 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.40 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $17.40 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $17.40 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 488 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
488 | 63 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 488 | 63 |
| Furosemide | Furosemide | 426 | 86 |
| Atorvastatin Calcium | Atorvastatin Calcium | 377 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 335 | 61 |
| Mirtazapine | Mirtazapine | 226 | 45 |
| Trazodone Hcl | Trazodone Hcl | 225 | 52 |
| Amlodipine Besylate | Amlodipine Besylate | 196 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 194 | 41 |
| Sertraline Hcl | Sertraline Hcl | 194 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 185 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 168 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 160 | 43 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 158 | 28 |
| Losartan Potassium | Losartan Potassium | 158 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 155 | 41 |
| Potassium Chloride | Potassium Chloride | 148 | 34 |
| Memantine Hcl | Memantine Hcl | 142 | 29 |
| Metformin Hcl | Metformin Hcl | 128 | 34 |
| Omeprazole | Omeprazole | 120 | 34 |
| Divalproex Sodium | Divalproex Sodium | 118 | 21 |
| Buspirone Hcl | Buspirone Hcl | 116 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 25 |
| Donepezil Hcl | Donepezil Hcl | 113 | 24 |
| Lisinopril | Lisinopril | 101 | 27 |
| Levetiracetam | Levetiracetam | 97 | 19 |
| Carvedilol | Carvedilol | 96 | 23 |
| Allopurinol | Allopurinol | 85 | 13 |
| Finasteride | Finasteride | 83 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 83 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 83 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 82 | 28 |
| Scopolamine | Scopolamine | 81 | 14 |
| Jardiance | Empagliflozin | 80 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 77 | 21 |
| Famotidine | Famotidine | 76 | 23 |
| Latanoprost | Latanoprost | 75 | 21 |
| Novolog Flexpen | Insulin Aspart | 74 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 73 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 18 |
| Simvastatin | Simvastatin | 67 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 65 | 13 |
| Memantine Hcl Er | Memantine Hcl | 65 | suppressed |
| Lactulose | Lactulose | 63 | 13 |
| Clozapine | Clozapine | 60 | suppressed |
| Myrbetriq | Mirabegron | 60 | suppressed |
| Nystatin | Nystatin | 57 | 32 |
| Trulicity | Dulaglutide | 57 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 56 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | suppressed |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Lamotrigine | Lamotrigine | 52 | 12 |
| Montelukast Sodium | Montelukast Sodium | 52 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 50 | 15 |
| Baclofen | Baclofen | 50 | 13 |
| Cephalexin | Cephalexin | 50 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | suppressed |
| Gabapentin | Gabapentin | 49 | 19 |
| Ondansetron Odt | Ondansetron | 49 | 16 |
| Prednisone | Prednisone | 47 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Lorazepam | Lorazepam | 45 | 24 |
| Ondansetron Hcl | Ondansetron Hcl | 44 | 32 |
| Bumetanide | Bumetanide | 43 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 43 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 41 | 11 |
| Entresto | Sacubitril/Valsartan | 40 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 35 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 35 | suppressed |
| Acetic Acid | Acetic Acid | 34 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | suppressed |
| Budesonide | Budesonide | 33 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 33 | 16 |
| Spironolactone | Spironolactone | 33 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 13 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 30 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 24 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 27 | 14 |
| Gemtesa | Vibegron | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 12 |
| Olanzapine | Olanzapine | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | 11 |
| Tramadol Hcl | Tramadol Hcl | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Erythromycin | Erythromycin Base | 22 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 22 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 22 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 22 | 18 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Glipizide | Glipizide | 20 | suppressed |
| Risperidone | Risperidone | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 19 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Azithromycin | Azithromycin | 18 | 11 |
| Klayesta | Nystatin | 18 | 14 |
| Methocarbamol | Methocarbamol | 18 | 12 |
| Ramelteon | Ramelteon | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Cyclosporine | Cyclosporine | 16 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Humulin R | Insulin Regular, Human | 15 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | 12 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Zonisamide | Zonisamide | 14 | suppressed |
| Restasis | Cyclosporine | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Trimethoprim | Trimethoprim | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Exemestane | Exemestane | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.40 · 1 records | PFIZER INC. | ELIQUIS, NURTEC ODT | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error